These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 7545143)
1. Tumor-infiltrating T lymphocytes from renal-cell carcinoma express B7-1 (CD80): T-cell expansion by T-T cell co-stimulation. Thurnher M; Radmayr C; Hobisch A; Böck G; Romani N; Bartsch G; Klocker H Int J Cancer; 1995 Sep; 62(5):559-64. PubMed ID: 7545143 [TBL] [Abstract][Full Text] [Related]
2. Expression of costimulatory molecules CD80 and CD86 and their receptors CD28, CTLA-4 on malignant ascites CD3+ tumour-infiltrating lymphocytes (TIL) from patients with ovarian and other types of peritoneal carcinomatosis. Melichar B; Nash MA; Lenzi R; Platsoucas CD; Freedman RS Clin Exp Immunol; 2000 Jan; 119(1):19-27. PubMed ID: 10606960 [TBL] [Abstract][Full Text] [Related]
3. In situ expression of B7 and CD28 receptor families in human malignant melanoma: relevance for T-cell-mediated anti-tumor immunity. Denfeld RW; Dietrich A; Wuttig C; Tanczos E; Weiss JM; Vanscheidt W; Schöpf E; Simon JC Int J Cancer; 1995 Jul; 62(3):259-65. PubMed ID: 7543078 [TBL] [Abstract][Full Text] [Related]
4. Costimulation of T-cell activation and virus production by B7 antigen on activated CD4+ T cells from human immunodeficiency virus type 1-infected donors. Haffar OK; Smithgall MD; Bradshaw J; Brady B; Damle NK; Linsley PS Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11094-8. PubMed ID: 7504294 [TBL] [Abstract][Full Text] [Related]
5. B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses. Zhang YQ; Joost van Neerven RJ; Van Gool SW; Coorevits L; de Boer M; Ceuppens JL Int Immunol; 1997 Aug; 9(8):1095-102. PubMed ID: 9263006 [TBL] [Abstract][Full Text] [Related]
6. T cell activation by antigens on human melanoma cells--co-stimulation by B7-1 is neither sufficient nor necessary to stimulate IL-2 secretion by melanoma-specific T cell clones in vitro. Viret C; Gervois N; Guilloux Y; Le Dréan E; Diez E; Jotereau F Int Immunol; 1995 Oct; 7(10):1535-43. PubMed ID: 8562498 [TBL] [Abstract][Full Text] [Related]
7. Induction of autologous tumor-specific cytotoxic T-lymphocyte activity against a human renal carcinoma cell line by B7-1 (CD8O) costimulation. Wang YC; Zhu L; McHugh R; Graham SD; Hillyer CD; Dillehay D; Sell KW; Selvaraj P J Immunother Emphasis Tumor Immunol; 1996 Jan; 19(1):1-8. PubMed ID: 9147700 [TBL] [Abstract][Full Text] [Related]
8. Soluble CD80 Protein Delays Tumor Growth and Promotes Tumor-Infiltrating Lymphocytes. Horn LA; Long TM; Atkinson R; Clements V; Ostrand-Rosenberg S Cancer Immunol Res; 2018 Jan; 6(1):59-68. PubMed ID: 29122838 [TBL] [Abstract][Full Text] [Related]
9. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma. Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129 [TBL] [Abstract][Full Text] [Related]
10. A pathway of costimulation that prevents anergy in CD28- T cells: B7-independent costimulation of CD1-restricted T cells. Behar SM; Porcelli SA; Beckman EM; Brenner MB J Exp Med; 1995 Dec; 182(6):2007-18. PubMed ID: 7500046 [TBL] [Abstract][Full Text] [Related]
11. B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells. Caux C; Vanbervliet B; Massacrier C; Azuma M; Okumura K; Lanier LL; Banchereau J J Exp Med; 1994 Nov; 180(5):1841-7. PubMed ID: 7525840 [TBL] [Abstract][Full Text] [Related]
12. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule. McLellan AD; Starling GC; Williams LA; Hock BD; Hart DN Eur J Immunol; 1995 Jul; 25(7):2064-8. PubMed ID: 7542604 [TBL] [Abstract][Full Text] [Related]
14. Defective B7 expression on antigen-presenting cells underlying T cell activation abnormalities in systemic lupus erythematosus (SLE) patients. García-Cózar FJ; Molina IJ; Cuadrado MJ; Marubayashi M; Peña J; Santamaría M Clin Exp Immunol; 1996 Apr; 104(1):72-9. PubMed ID: 8603537 [TBL] [Abstract][Full Text] [Related]
15. FOXP3 induced by CD28/B7 interaction regulates CD25 and anergic phenotype in human CD4+CD25- T lymphocytes. Scottà C; Soligo M; Camperio C; Piccolella E J Immunol; 2008 Jul; 181(2):1025-33. PubMed ID: 18606654 [TBL] [Abstract][Full Text] [Related]
16. CD28 ligands CD80 (B7-1) and CD86 (B7-2) induce long-term autocrine growth of CD4+ T cells and induce similar patterns of cytokine secretion in vitro. Levine BL; Ueda Y; Craighead N; Huang ML; June CH Int Immunol; 1995 Jun; 7(6):891-904. PubMed ID: 7577797 [TBL] [Abstract][Full Text] [Related]
17. Selective lysis of autologous tumor cells by recurrent gamma delta tumor-infiltrating lymphocytes from renal carcinoma. Choudhary A; Davodeau F; Moreau A; Peyrat MA; Bonneville M; Jotereau F J Immunol; 1995 Apr; 154(8):3932-40. PubMed ID: 7706731 [TBL] [Abstract][Full Text] [Related]
18. Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor-infiltrating lymphocytes. Wang Q; Redovan C; Tubbs R; Olencki T; Klein E; Kudoh S; Finke J; Bukowski RM Int J Cancer; 1995 Jun; 61(6):780-5. PubMed ID: 7790111 [TBL] [Abstract][Full Text] [Related]
19. Identification of residues in the V domain of CD80 (B7-1) implicated in functional interactions with CD28 and CTLA4. Fargeas CA; Truneh A; Reddy M; Hurle M; Sweet R; Sékaly RP J Exp Med; 1995 Sep; 182(3):667-75. PubMed ID: 7544393 [TBL] [Abstract][Full Text] [Related]
20. Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV-infected subjects. Vingerhoets JH; Vanham GL; Kestens LL; Penne GG; Colebunders RL; Vandenbruaene MJ; Goeman J; Gigase PL; De Boer M; Ceuppens JL Clin Exp Immunol; 1995 Jun; 100(3):425-33. PubMed ID: 7539725 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]